Trial intelligence / Profile preview

Moringa Leaf Extract in Rheumatoid Arthritis

NCT05665985Phase 2Completed

Sponsor
Universitas Sebelas Maret
Start
May 2020
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Keloreena in rheumatoid arthritis (RA), sponsored by Universitas Sebelas Maret. Started May 2020; status: completed.

02

Drugs

Keloreena
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT05665985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05665985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call